AOD 9604 5mg Vial

45 £

In Stock

8 in stock

Overview:

AOD 9604 is a synthetic peptide fragment derived from the C-terminal region

(amino acids 176–191) of human growth hormone (hGH). It was developed to

isolate potential fat-metabolism effects of growth hormone while minimizing

effects on growth and insulin-like growth factor-1 (IGF-1).

Proposed Mechanism (Preclinical Research)

Research suggests AOD 9604 may:

Stimulate lipolysis (breakdown of stored fat)
Inhibit lipogenesis (formation of new fat)
Act on adipose tissue without significantly affecting blood glucose levels
Avoid strong stimulation of IGF-1 pathways associated with full-length growth hormone

Unlike growth hormone itself, AOD 9604 is designed to target metabolic

pathways more selectively.

Research Areas

AOD 9604 has been investigated in:

Clinical trials have been conducted in obesity, but large-scale regulatory

approvals for prescription use have not been broadly established in major

markets.

Evidence & Regulatory Status

Studied in human clinical trials for obesity
Not widely approved as a prescription medication
Often sold as “research use only” in non-pharmaceutical formulations
Long-term safety data remain limited outside formal clinical development programs

FOR RESEARCH USE ONLY